Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 이지희 | * |
| dc.contributor.author | 박은미 | * |
| dc.contributor.author | 최윤희 | * |
| dc.contributor.author | 김용배 | * |
| dc.date.accessioned | 2018-11-23T16:30:07Z | - |
| dc.date.available | 2018-11-23T16:30:07Z | - |
| dc.date.issued | 2017 | * |
| dc.identifier.issn | 1949-2553 | * |
| dc.identifier.other | OAK-23780 | * |
| dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/247011 | - |
| dc.description.abstract | The invasion of activated fibroblasts is a key mechanism of tissue fibrosis pathology. The recognition and uptake of apoptotic cells can induce the anti-fibrogenic programming of macrophages. We demonstrate that after interacting with apoptotic cells, macrophages secrete bioactive molecules that antagonize TGF-beta 1-induced increases in myofibroblast (fibroproliferative) phenotypic markers and reduce the enhanced invasive capacity of TGF-beta 1- or EGF-treated mouse lung fibroblasts (MLg). Furthermore, numerous treatment strategies prevented the anti-fibrotic effects of conditioned media, including transfection of macrophages with COX-2 or RhoA siRNAs or treatment of MLg cells with receptor antagonists for prostaglandin E-2 (PGE(2)), PGD(2), or hepatocyte growth factor (HGF). Additionally, administration of apoptotic cells in vivo inhibited the bleomycin-mediated invasive capacity of primary fibroblasts, as well as adhesion and extracellular matrix protein mRNA expression. These data suggest that the anti-fibrogenic programming of macrophages by apoptotic cells can be used as a novel tool to control the progressive fibrotic reaction. | * |
| dc.language | English | * |
| dc.publisher | IMPACT JOURNALS LLC | * |
| dc.subject | apoptotic cells | * |
| dc.subject | macrophages | * |
| dc.subject | lung fibroblasts | * |
| dc.subject | myofibroblast | * |
| dc.subject | invasion | * |
| dc.title | Interaction of macrophages with apoptotic cells inhibits transdifferentiation and invasion of lung fibroblasts | * |
| dc.type | Article | * |
| dc.relation.issue | 68 | * |
| dc.relation.volume | 8 | * |
| dc.relation.index | SCOPUS | * |
| dc.relation.startpage | 112297 | * |
| dc.relation.lastpage | 112312 | * |
| dc.relation.journaltitle | ONCOTARGET | * |
| dc.identifier.doi | 10.18632/oncotarget.22737 | * |
| dc.identifier.wosid | WOS:000419569800013 | * |
| dc.identifier.scopusid | 2-s2.0-85038828597 | * |
| dc.author.google | Kim, Yong-Bae | * |
| dc.author.google | Yoon, Young-So | * |
| dc.author.google | Choi, Youn-Hee | * |
| dc.author.google | Park, Eun-Mi | * |
| dc.author.google | Kang, Jihee Lee | * |
| dc.contributor.scopusid | 이지희(7404517577) | * |
| dc.contributor.scopusid | 박은미(35933416400) | * |
| dc.contributor.scopusid | 최윤희(7404776849) | * |
| dc.contributor.scopusid | 김용배(57225051380) | * |
| dc.date.modifydate | 20260622145141 | * |